Purdue Pharma Faces $5.5B Criminal Sentence for Deceiving Regulators and Boosting Opioid Sales
- Posted on April 30, 2026
- By International Business Times
- 0 Views
- 1 min read
Purdue Pharma Faces $5.5B Criminal Sentence for Deceiving Regulators and Boosting Opioid Sales
Purdue Pharma has been sentenced to pay $5.5 billion after pleading guilty to deceiving regulators and fueling the US opioid crisis through aggressive and illegal opioid sales practices.